Breaking News

LivaNova to Divest Cardiac Rhythm Management Business to Microport Scientific

The transaction is expected to close in the second quarter of 2018.

LivaNova to Divest Cardiac Rhythm Management Business to Microport Scientific

Related CONTENT

Business Wire03.08.18

LivaNova PLC announced that it has entered into a definitive Stock and Asset Purchase Agreement (“Purchase Agreement”) to divest its Cardiac Rhythm Management business franchise to MicroPort Scientific Corporation. LivaNova and MicroPort executed and delivered the Purchase Agreement, pursuant to the terms of a binding Letter of Intent, previously announced on November 20, 2017.

Today’s announcement follows the successful completion of works council information and consultation requirements in France. The proposed transaction is subject to customary regulatory and other closing conditions. The transaction is expected to close in the second quarter of 2018.

Related Searches

Related Knowledge Center

Cardiovascular

Suggested For You

LivaNova Announces CE Mark for PureFlex Arterial Cannulae Line for Conventional Cardiac Surgery

LivaNova Announces CE Mark for PureFlex Arterial Cannulae Line for Conventional Cardiac Surgery

LivaNova to Acquire TandemLife for $250M

LivaNova to Acquire TandemLife for $250M

'CyberHeart' Supercomputer Remotely Assesses Deviations in Heart Condition

LivaNova Awards ECA with 2017 Supplier of the Year

LivaNova Awards ECA with 2017 Supplier of the Year

LivaNova to Acquire ImThera Medical

LivaNova to Acquire ImThera Medical

ERT Acquires iCardiac Technologies

ERT Acquires iCardiac Technologies

University-Developed Mitral Valve Repair System Proven Safe & Effective

University-Developed Mitral Valve Repair System Proven Safe & Effective

LivaNova Receives FDA Approvals for SenTiva Device, Next-Generation VNS Therapy Programming System

LivaNova Receives FDA Approvals for SenTiva Device, Next-Generation VNS Therapy Programming System

Abbott Launches First & Only Smartphone Compatible Insertable Cardiac Monitor in U.S.

Abbott Launches First & Only Smartphone Compatible Insertable Cardiac Monitor in U.S.

LivaNova and MicroPort Receive CFDA Approval of Rega Pacemakers

LivaNova and MicroPort Receive CFDA Approval of Rega Pacemakers

A Cardiac Implant that Grows with a Child

A Cardiac Implant that Grows with a Child

LivaNova's Latest VNS Therapy System for Epilepsy Wins FDA Nod

Aziyo Completes Enrollment in Prospective Post Market Study of CanGaroo ECM Envelope

Aziyo Completes Enrollment in Prospective Post Market Study of CanGaroo ECM Envelope

Related Breaking News

Cardiovascular | Digital Health | Patient Monitoring

VivaLNK Announces World's First FDA Cleared Wearable ECG Sensor Platform

Reusable patch and software development kit gives solution providers direct control over data.
VivaLNK 01.21.20
Cardiovascular

World's Smallest Pacemaker Can Now Treat AV Block

Medtronic's Micra AV is now FDA approved for atrioventricular (AV) block, impaired electrical signals between the heart.
GlobeNewswire 01.21.20
Cardiovascular

Data Shows Favorable Outcomes With TCAR vs. Carotid Endarterectomy for Carotid Artery Disease

TCAR continues to demonstrate a low stroke, death rate equivalent to CEA with lower rates of myocardial infarction and cranial nerve injury.
Silk Road Medical Inc. 01.20.20
Cardiovascular | Surgical

Cook Medical Launches TriForce Peripheral Crossing Set

Supports procedures to treat patients with vascular obstructions.
Business Wire 01.15.20
Cardiovascular

Trial Data Show PleuraFlow Enables Improved Quality and Cost of Care for Cardiac Patients

Reduction of patient complications and hospital resource utilization after heart surgery demonstrated with the use of the PleuraFlow ACT System.
Business Wire 01.15.20
Cardiovascular

Data Show Zilver PTX Leads to Fewer Complications, Shorter Hospital Stays

Additionally, the procedure with Zilver PTX takes about half the time as bypass surgery.
Business Wire 01.15.20
Cardiovascular

Medtronic Gains CE Mark for InterStim Neurostimulator and MRI Leads

Offers lifestyle-friendly choices in sacral neuromodulation therapy to Europeans suffering from incontinence.
Medtronic plc 01.13.20
Cardiovascular | Surgical

Abbott to Begin MitraClip Trial for Moderate Risk Patients

Will assess transcatheter mitral valve repair against the current standard of care surgery.
Abbott Laboratories 01.13.20
Cardiovascular | Patient Monitoring

Masimo Claims Apple Stole Health Monitoring Tech for Apple Watch

Masimo has filed a patent infringement lawsuit and alleges poaching of trade secrets.
Sam Brusco, Associate Editor 01.10.20
Cardiovascular | Surgical

JenaValve's TAVR Wins Breakthrough Status

This designation is for severe aortic regurgitation (AR) and AR-dominant mixed aortic valve disease.
Business Wire 01.10.20
Cardiovascular | Materials | Neurological

Biomaterial Under Development Could Improve Cerebral Aneurysm Treatment

"PPODA-QT" could effectively plug the ballooning aneurysm, enabling tissue to regrow over the material and heal the main vessel.
Northern Arizona University 01.09.20
Cardiovascular

Reflow Medical’s Temporary Spur Stent Wins Breakthrough Status

The stent system treats of below-the-knee peripheral artery disease.
Business Wire 01.09.20
Cardiovascular

FDA OKs Penumbra's Indigo Aspiration System for Pulmonary Embolism

The continuous aspiration mechanical thrombectomy system removes clots from arteries and veins in the peripheral vasculature.
Business Wire 01.09.20
Cardiovascular | Neurological

Terumo's MicroVention Wins FDA Nod for Aneurysm Flow Diverter

First flow diverter in the U.S. to use a self-expanding braided nitinol mesh to help re-direct blood flow and promote aneurysm occlusion.
PR Newswire 01.09.20
Cardiovascular

Breakthrough Device Designation Granted for Revivent TC Transcatheter Ventricular Enhancement System

The system from BioVentrix has received the CE Mark and is commercially available in Europe.
Business Wire 01.09.20